Industry heavyweight Mitsubishi Fuso has signed a deal with electric van startup REE Automotive to co-develop software-defined and x-by-wire technology for the next-generation of medium-duty delivery ...

InnoCare begins patient dosing in global phase II trial of TYK2 inhibitor, Soficitinib to treat prurigonodularis: Beijing Monday, December 1, 2025, 12:00 Hrs [IST] InnoCarePharma, ...

Ranked by Square feet developed, last five years in Triad Showcase your company news with guaranteed exposure both in print and online Trends, Opportunities and the Road Ahead A panel of real estate ...

Intel has responded to TSMC, alleging that a former semiconductor staffer leaked trade secrets and confidential information ...

Soficitinib is a potent and selective TYK2 inhibitor that is being developed for the treatment of various T-cell related autoimmune disorders. The Current indications under development are ...

The use of IL-1 alpha and beta inhibition with ARCALYST has increasingly become the preferred treatment for recurrent ...

Phoenix, AZ — December 2025 — This Christmas, Phoenix families and businesses can give a gift that… At U & Improved, we believe leadership isn’t a title, it’s a mindset. Our… Join us as we unveil the ...

US drugmaker AbbVie has announced two updates for Canadians living with ulcerative colitis (UC) in relation to its drug ...

The huge fire that ripped through a former nightclub in Wigan is being investigated as possible arson, say police. Emergency ...

India’s economy grew at a robust 8.2 pc in second quarter (July–Sept) of the current financial year, up from 5.6 per cent in the same quarter ...

According to research by SNS Insider, the U.S. Atopic Dermatitis Drugs Market is projected to grow at a CAGR of 8.57%, supported by high disease burden, strong R&D pipelines, and rapid adoption of ...

InnoCare Pharma (HKEX: 9969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, announced today ...